Front Page News

New Report Highlights Caregiving Challenges of Individuals with Spinal Muscular Atrophy

February 16, 2024
Posted in ,

Cure SMA released a national report on National Caregivers Day that chronicles the caregiving challenges experienced by individuals with spinal muscular atrophy (SMA) and recommends […]

Read More ›

Cure SMA is Thrilled to Announce the Establishment of our New Chapter in Puerto Rico!

February 7, 2024
Posted in ,

Led by Keishla Rolon, Ramon Rivera Vega, Elizabeth Serrano, Natasha Santiago, and Brenda Luciano, Cure SMA’s Puerto Rico chapter has already been hard at work […]

Read More ›

Spring 2024 Walk-n-Roll Registration is NOW OPEN!

January 18, 2024
Posted in ,

Cure SMA is excited to officially open registration for our Spring 2024 Walk-n-Roll events! By participating in our Walk-n-Roll, you can make a real difference in […]

Read More ›

100% of States Now Screening Newborns for SMA

January 3, 2024
Posted in , ,

You did it!   We’ve now reached our goal of 100 percent newborn screening of spinal muscular atrophy (SMA) in all 50 states with the […]

Read More ›

Nevada Starts Screening for SMA – Only One State Remains!

December 21, 2023
Posted in , ,

Nevada has become the 49th state to begin screening for spinal muscular atrophy (SMA). Nevada State Public Health Laboratory officials confirmed with Cure SMA that […]

Read More ›

Analysis: Cure SMA’s Risk/Benefit Survey

December 20, 2023
Posted in , ,

One of Cure SMA’s top priorities is to relay the SMA community’s treatment experiences and preferences to the United States Food and Drug Administration (FDA). […]

Read More ›

Winter Immunization Recommendations

December 12, 2023
Posted in

Cooler weather serves as a reminder to explore how to keep ourselves healthy through the cold and flu season. What you can do to protect […]

Read More ›

Novartis Gene Therapies Releases SMA Community Statement

December 11, 2023
Posted in , ,

This week, Novartis Gene Therapies released an SMA community statement detailing the progress on enrollment for both STEER and STRENGTH clinical trials, their investigational intrathecal […]

Read More ›

Genentech Releases SMA Community Letter with Evrysdi (risdiplam) Updates

December 7, 2023
Posted in ,

Our partners at Genentech recently provided an SMA Community Letter regarding Evrysdi® (risdiplam) and their clinical development program. Visit this link to learn more.

Read More ›

Cure SMA Featured in the NFL’s My Cause My Cleats

December 5, 2023
Posted in

Cure SMA is thrilled to have recently been featured in the National Football League’s (NFL) My Cause My Cleats campaign. Through this fantastic initiative, players […]

Read More ›
Scroll to Top